Model Number 72081-01 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Erythema (1840); Hemorrhage/Bleeding (1888); Pain (1994); Fluid Discharge (2686); Skin Infection (4544); Skin Inflammation/ Irritation (4545)
|
Event Date 04/11/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
The product has been requested back for an investigation.A follow-up report will be submitted once additional information is obtained.The device mfg date is unknown.The date entered is the date abbott diabetes care became aware of the event.All pertinent information available to abbott diabetes care has been submitted.
|
|
Event Description
|
An adverse skin reaction was reported with wear of the abbott diabetes care (adc) device.As a result, customer experienced inflammation, "spot turned red", "pus", painful, bleeding, "insertion site infection" and received third-party treatment of bepanthen skin cream and benzidan anti-fungal (dose unspecified) by a healthcare professional.There was no report of death or permanent injury associated with this event.
|
|
Manufacturer Narrative
|
Repeated attempts by adc to retrieve the product were unsuccessful and/or the customer discarded the product.No product has been returned and an extended investigation has been performed for the reported complaint.There was no indication that the product did not meet specification.The reported complaint is related to skin irritation or an allergic reaction to the patch adhesive of the freestyle libre sensor.Dhrs (device history review) for the freestyle libre sensor and freestyle libre sensor kit were reviewed and the dhrs showed the freestyle libre sensor and freestyle libre sensor kit passed all tests prior to release.Dose audit reports were reviewed and demonstrates the continued effectiveness of the established sterilization process for libre sensor products.Environmental monitoring reports were reviewed, including bioburden and endotoxin testing, and demonstrated that all monitoring processes continue to meet adc minimum requirements for product quality.If the product is returned, a physical investigation will be performed and a follow-up report submitted.All pertinent information available to abbott diabetes care has been submitted.
|
|
Event Description
|
An adverse skin reaction was reported with wear of the abbott diabetes care (adc) device.As a result, customer experienced inflammation, "spot turned red", "pus", painful, bleeding, "insertion site infection" and received third-party treatment of bepanthen skin cream and benzidan anti-fungal (dose unspecified) by a healthcare professional.There was no report of death or permanent injury associated with this event.
|
|
Search Alerts/Recalls
|